buy medicine online indiamedicine onlineloading...
    Cancer screening blood tests
    Cancer screening from the comfort of your home
    Early detection of cancer is vital for successful treatment and cure. Failure of timely detection invariably leads to intensive and toxic treatments, high treatment costs and treatment failure.
    Introducing: EasyCheck360®
    A revolutionary multi-cancer early-stage detection test based on a simple blood test.
    • Convenient blood test for asymptomatic individuals in the age of 35 years & above
    • Covers 30+ types of cancers including Breast, Ovary, Lung, Colon, Pancreas, Liver & more
    Starting at 6000
    & Radiation Free
    At-home blood
    Sample Collection
      • EasyCheck360
        Multi-cancer screening
        Detects 30 types of cancer
        Including Lung, Kidney, Gallbladder, Ovaries, Prostate and more
        At 14000 only
      • EasyCheck - Diabetes
        Cancer screening test for people with diabetes. Detects 6 types of cancers
        Including Liver, Gallbladder, Pancreas, Kidney, Bladder and Colon Cancers
        At 9000 only
      • EasyCheck - Femmesafe
        Cancer screening test for women
        Detects 4 types of cancers
        Including Breast, Ovarian, Endometrial and Cervical Cancers
        At 9000 only
      • EasyCheck - Prostate
        Cancer screen test for Men
        Detects prostate cancer
        Includes detection of
        Prostate Cancer
        At 6000 only
    EasyCheck360® is the outcome of intensive research efforts of the last several years by internationally recognized scientists and doctors. It has been rigorously validated for its analytical and clinical performance characteristics. Datar Cancer Genetics is a global oncology research and applications company specializing in non-invasive technologies for improved detection, treatment, and management of cancer. The company's state-of-the-art facility is NABL, ISO, CAP, and CLIA accredited. The Company serves cancer patients and suspected cases in the UK, European Union, United States, GCC, and India. The company is pursuing large clinical studies in Europe and in the United States to cover multiple cancers where there is a potential of cure with early detection. The company also proposes to have multiple test centers globally.
    Need help?
    Get a call back from our health advisor
    Frequently Asked Questions
    It helps to detect the existence of cancer.
    This test is not intended to be and should not be considered as a replacement for any Standard of Care screening tests.
    Within the limits of error, a 'negative' result is a reasonable indication of undetectable cancer of the type covered by the test. For other cancers not covered by the test, no inference should be drawn from a 'negative' result.
    As EasyCheck360 is a non-invasive blood test, there is no disadvantage in frequent testing. However, we advise that EasyCheck360® should be performed every 12 months in case of negative results.
    No, such individuals should seek expert medical advice without delay.
    The test indicates the location for the select types of cancers with high accuracy, and in others, the tissue of origin can be identified with reasonable accuracy. In all cases of 'positive' results, the report should be interpreted by your physician who can guide you on the further course of action.

    LegitScript is a verification and monitoring service for online pharmacies
    Trusted by more than 18 million people
    Trusted by more than 20 million people
    All content is authored by 1mg Editorial Team
    All content is authored by Tata 1mg Editorial Team
    We are certified "ISO/IEC 27001:2013"
    We are certified
    "ISO/IEC 27001:2013"